News – Page 502 – Endpoints News

New York AG accuses Teva of lying over opioid crisis to evade legal action

3 years ago

Emergent nets another manufacturing deal, this time for Ridgeback's Ebola treatment

3 years ago

Congressional reps push FDA to adopt ‘clear, conspicuous and neutral’ rule for pharma drug ads

3 years ago

HRA Pharma seeks approval for first-ever OTC birth control pill in the US

3 years ago

Pliant claims early win for integrin inhibitor in challenging IPF space — shares soar

3 years ago

CBO projects Senate drug pricing bill would cut the development of 10 drugs over 30 years

3 years ago

Covid-19 roundup: EMA recommends an additional booster dose; Moderna touts shot targeting Omicron subvariants

3 years ago

Updated: Different way to go after KRAS mutant tumors? Novo-backed biotech nabs $50M to wrap early studies

3 years ago

Vertex nabs ViaCyte's rival diabetes stem cell treatment, acquiring the biotech for $320M in cash

3 years ago

Ionis hands off an antisense drug for kidney disease, giving all rights to Roche

3 years ago

Florida Gov. DeSantis hints at suing FDA over stalled Canadian drug import plan

3 years ago

La Jolla exits to Innoviva in a deal that caps 33 years marked by misses in lupus, malaria and beta thalassemia

3 years ago

VC dollars keep rolling in as Qiming ties a ribbon on $2.5B Fund VIII

3 years ago

Two years after scrapping three hemophilia trials, Novo Nordisk plots route to FDA with new PhIII data

3 years ago

In wake of unexpected patient deaths, MacroGenics closes down PhII cancer trial

3 years ago

Sanofi’s next-gen hemophilia drugs take a PhIII bow — but can they still make their mark at this stage?

3 years ago

Bispecific M&A reaches AstraZeneca; Countdown for Merck's big bid; Biotech buyout in savage times; and more

3 years ago

FDA says it won't allow state-licensed pharmacists to prescribe Merck's Lagevrio

3 years ago

Horizon nabs FDA expanded label for gout med Krystexxa

3 years ago

Sinopharm mulls $1B buyout of China-based DNA synthesis company — report

3 years ago

Another Indian drug manufacturer hit with a Form 483 over recent observations

3 years ago

German chemicals company to expand its reach into mRNA ingredient production

3 years ago

Certain discarded drugs will soon cost pharma companies

3 years ago

Trio of biotechs raise funds to make enzymes and develop drugs for IBS and other autoimmune diseases

3 years ago

First page Previous page 499 500 501502503 504 505 Next page Last page